6.90
-0.25
(-3.50%)
At close: April 16 at 9:35:14 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 21 | 21 | 23 | 22 |
Avg. Estimate | 295.6M | 293.31M | 1.19B | 1.23B |
Low Estimate | 294.02M | 276.6M | 1.15B | 1.13B |
High Estimate | 297.08M | 298.43M | 1.21B | 1.29B |
Year Ago Sales | 310.1M | 291.5M | 1.21B | 1.19B |
Sales Growth (year/est) | -4.68% | 0.62% | -1.73% | 3.20% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ZOM.SG | -- | -- | -- | -- |
S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/16/2025 |
Maintains | Mizuho: Neutral to Neutral | 4/15/2025 |
Maintains | DA Davidson: Neutral to Neutral | 4/14/2025 |
Maintains | Scotiabank: Sector Perform to Sector Perform | 2/27/2025 |
Maintains | Canaccord Genuity: Buy to Buy | 2/26/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/26/2025 |